Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 10:45AM EDT
Show:
Annual
Income statement
All numbers in thousandsBreakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
40,686,074
41,399,540
43,951,547
39,011,184
30,306,981
Cost of revenue
21,378,222
21,595,309
23,169,690
20,229,785
13,733,529
Gross profit
19,307,852
19,804,231
20,781,856
18,781,400
16,573,452
Operating expenses
Research development
4,206,740
4,346,045
4,302,093
3,837,303
2,795,494
Selling general and administrative
10,623,239
10,887,080
10,159,238
9,957,963
9,106,276
Total operating expenses
17,844,474
18,240,907
17,145,017
16,071,627
13,743,290
Operating income or loss
1,463,378
1,563,324
3,636,840
2,709,773
2,830,163
Interest expense
1,387,919
1,324,831
963,807
822,534
880,952
Income before tax
2,898,228
3,264,568
4,574,382
6,042,671
4,677,844
Income tax expense
331,197
369,504
626,917
1,066,401
737,865
Income from continuing operations
2,567,030
2,895,063
3,947,464
4,976,269
3,939,980
Net income
2,009,028
2,386,266
3,730,805
4,728,711
3,662,813
Net income available to common shareholders
2,009,028
2,386,266
3,730,805
4,728,711
3,662,813
Basic EPS
1.35
0.89
1.43
1.85
1.43
Diluted EPS
1.34
0.89
1.43
1.85
1.43
Basic average shares
2,656,224
2,681,198
2,608,954
2,556,060
2,561,408
Diluted average shares
2,679,648
2,681,198
2,608,954
2,556,060
2,561,408
© 2024 Yahoo. All rights reserved.